Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2017
Somatostatin Receptor Antagonists for Imaging and Therapy
Melpomeni Fani, Guillaume P Nicolas, Damian Wild
Cancers
|
March 10, 2022
Radiolabeled Somatostatin Analogs-A Continuously Evolving Class of Radiopharmaceuticals
Melpomeni Fani, Rosalba Mansi, Guillaume P Nicolas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 22, 2018
New Developments in Peptide Receptor Radionuclide Therapy
Guillaume P Nicolas, Alfred Morgenstern, Margret Schottelius, et al.
Swiss Medical Weekly
|
November 19, 2018
Clinical presentation of 54 patients with endogenous hyperinsulinaemic hypoglycaemia: a neurological chameleon (observational study)
Luca G Valente, Kwadwo Antwi, Guillaume P Nicolas, et al.
EJNMMI Research
|
August 7, 2020
A new <sup>68</sup>Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting
Rosalba Mansi, Karim Abid, Guillaume P Nicolas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 29, 2017
Biodistribution, Pharmacokinetics, and Dosimetry of <sup>177</sup>Lu-, <sup>90</sup>Y-, and <sup>111</sup>In-Labeled Somatostatin Receptor Antagonist OPS201 in Comparison to the Agonist <sup>177</sup>Lu-DOTATATE: The Mass Effect
Guillaume P Nicolas, Rosalba Mansi, Lisa McDougall, et al.
Endocrine-Related Cancer
|
May 20, 2025
Impact of multikinase inhibitors in reshaping the treatment of advanced gastroenteropancreatic neuroendocrine tumors
Alexander R Siebenhüner, Julie Refardt, Guillaume P Nicolas, et al.
Reviews in Endocrine & Metabolic Disorders
|
June 5, 2020
Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges
Julie Refardt, Johannes Hofland, Antwi Kwadwo, et al.
Clinical Lung Cancer
|
August 6, 2023
3D-Quantitated Single Photon Emission Computed Tomography/Computed Tomography: Impact on intended Management Compared to Lung Perfusion Scan in Marginal Candidates for Pulmonary Resection
Makhmudbek Mallaev, Alin-Florin Chirindel, Didier Lardinois, et al.
Molecular Pharmaceutics
|
April 14, 2012
In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates
Melpomeni Fani, Maria-Luisa Tamma, Guillaume P Nicolas, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2017
Somatostatin Receptor Antagonists for Imaging and Therapy
Melpomeni Fani, Guillaume P Nicolas, Damian Wild
Cancers
|
March 10, 2022
Radiolabeled Somatostatin Analogs-A Continuously Evolving Class of Radiopharmaceuticals
Melpomeni Fani, Rosalba Mansi, Guillaume P Nicolas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 22, 2018
New Developments in Peptide Receptor Radionuclide Therapy
Guillaume P Nicolas, Alfred Morgenstern, Margret Schottelius, et al.
Swiss Medical Weekly
|
November 19, 2018
Clinical presentation of 54 patients with endogenous hyperinsulinaemic hypoglycaemia: a neurological chameleon (observational study)
Luca G Valente, Kwadwo Antwi, Guillaume P Nicolas, et al.
EJNMMI Research
|
August 7, 2020
A new <sup>68</sup>Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting
Rosalba Mansi, Karim Abid, Guillaume P Nicolas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 29, 2017
Biodistribution, Pharmacokinetics, and Dosimetry of <sup>177</sup>Lu-, <sup>90</sup>Y-, and <sup>111</sup>In-Labeled Somatostatin Receptor Antagonist OPS201 in Comparison to the Agonist <sup>177</sup>Lu-DOTATATE: The Mass Effect
Guillaume P Nicolas, Rosalba Mansi, Lisa McDougall, et al.
Endocrine-Related Cancer
|
May 20, 2025
Impact of multikinase inhibitors in reshaping the treatment of advanced gastroenteropancreatic neuroendocrine tumors
Alexander R Siebenhüner, Julie Refardt, Guillaume P Nicolas, et al.
Reviews in Endocrine & Metabolic Disorders
|
June 5, 2020
Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges
Julie Refardt, Johannes Hofland, Antwi Kwadwo, et al.
Clinical Lung Cancer
|
August 6, 2023
3D-Quantitated Single Photon Emission Computed Tomography/Computed Tomography: Impact on intended Management Compared to Lung Perfusion Scan in Marginal Candidates for Pulmonary Resection
Makhmudbek Mallaev, Alin-Florin Chirindel, Didier Lardinois, et al.
Molecular Pharmaceutics
|
April 14, 2012
In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates
Melpomeni Fani, Maria-Luisa Tamma, Guillaume P Nicolas, et al.
Page
of 3